Scinai Immunotherapeutics Ltd.
SCNI$17M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaJERUSALEM31 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 1, 2026
10dMarket Overview
Stock performance and key metrics
SCNI News
Catalyst Timeline
1 upcoming, 0 past
EarningsNext
SCNI Earnings Report
Jul 1, 2026Confirmed
FQ end 2026-03
Drug Pipeline
No drugs found in this phase.
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply